Callitas Health (Callitas Health) Receivables Turnover : 0.00 (As of Sep. 2020)

View and export this data going back to 2008. Start your Free Trial

What is Callitas Health Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Callitas Health's Revenue for the three months ended in Sep. 2020 was $0.04 Mil. Callitas Health's average Accounts Receivable for the three months ended in Sep. 2020 was $0.00 Mil.

Callitas Health Receivables Turnover Historical Data

The historical data trend for Callitas Health's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Callitas Health Receivables Turnover Chart

Callitas Health Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Receivables Turnover

Get a 7-Day Free Trial

29.65

32.82

6.48

Callitas Health Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Receivables Turnover	Get a 7-Day Free Trial															-	2.77	0.87	-	-

Competitive Comparison of Callitas Health's Receivables Turnover

For the Biotechnology subindustry, Callitas Health's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Callitas Health's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Callitas Health's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Callitas Health's Receivables Turnover falls into.

Callitas Health Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Callitas Health's Receivables Turnover for the fiscal year that ended in Dec. 2019 is calculated as

	Receivables Turnover (A: Dec. 2019 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2019 )	/ (	(Accounts Receivable (A: Dec. 2018 )	+	Accounts Receivable (A: Dec. 2019 ))	/	count )
=	0.538	/ (	(0	+	0.083)	/	1 )
=	0.538	/	0.083
=	6.48

Callitas Health's Receivables Turnover for the quarter that ended in Sep. 2020 is calculated as

	Receivables Turnover (Q: Sep. 2020 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Sep. 2020 )	/ (	(Accounts Receivable (Q: Jun. 2020 )	+	Accounts Receivable (Q: Sep. 2020 ))	/	count )
=	0.039	/ (	(0	+	0)	/	1 )
=	0.039	/	0
=	N/A

Callitas Health (OTCPK:MPHMF) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Callitas Health Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Callitas Health's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Callitas Health (Callitas Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Callitas Health Inc (OTCPK:MPHMF) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

734 - 1055 Dunsmuir Street, Vancouver, BC, CAN, V7X 1B1

Website

http://www.callitas.com

Callitas Health Inc is a clinical-stage company. It is engaged in developing technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications. The company's products offering includes ToConceive, C-103 Reformulated Orlistat, and Extrinsa. ToConceive is a fertility enhancing moisturizer. It is clinically proven to increase a woman's own natural conception lubrication, called transudate, to aid in conception. Orlistat is FDA-approved for weight management and sold by Roche as Xenical (prescription) and by GlaxoSmithKline as alli. Extrinsa focuses on women with orgasm and arousal difficulties. The topical, local, and the non-systemic product is also non-hormonal and does not affect the central nervous system.